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cDNA clones encoding the human kidney S-adenosylmethioninc synthetase (kidney-typ isoaymc) were isolated, The amino acid sequence deduced 
from thu cDNA indicates that this enzyme contains 395 amino acids and has a molecular mass oi’43.660 Da. The predicted amino acid sequence 
of this protein shares 84% similarity with that of human liver S-adenosylmcthionine synthctase (liver-type isoyme). In addition, the developmental 
expression of these two isotyme mRNAs has been studied in the human liver using the revcrsc transcription-polymerase chain reaction (RT-PCR). 
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I. INTRODUCTION 
S-Adenosylmethionine synthetase (MAT) (ATP:t- 
methioninc l~-adenosyltransferase (EC 2.5.1.6)), which 
Cantoni [I] first reported, is the enzyme that catalyzes 
the formation of S-adcnosylmethionine from methio- 
nine and ATP. S-Adenosylmethionine is an important 
methyl donor in most transmethylation reactions and is 
also the propyls.Tino donor in the biosynthesis of pol- 
yamines. Mamma:itin MAT exists as three different 
isoforms, designated a (or l), p (or I!:), and y (or II) 
[2,3]. The a and /3 forms are confined to the liver, 
whereas the y form is widely distributed in extra hepatic 
tissues [2,4,5]. The a andp forms purified from rat liver 
have been shown to be composed of four and two iden- 
tical subunits, respectively, of molecular mass 48 kDa 
on polyacrylamide gel electrophoresis [2,6]. Although 
the a and p forms of MAT differ in their properties, they 
are thought o be products of the same gene and, there- 
fore, represent different forms of the same enzyme 
(liver-type isozyme). In contrast, the y form (non-he- 
patic- or kidney-type isoyme) from human lympho- 
cytes contained three polypeptide bands of 53, 51, and 
38 kDa, and the 51 kDa protein appeared to be derived 
from the 53 kDa protein [S]. However, the function of 
each subunit remains to be established. 
Recently, liver-type MAT cDNAs have been isolated 
from rat [7,8] and human [9] liver cDNA libraries. In 
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addition, kidney-type isozyme cDNA has also been iso- 
lated from a rat kidney cDNA library [4]. Comparisons 
of amino acid sequences from these species revealed a
significant degree of homology. 
To study the regulation of the MAT gene in human 
cells it is necessary to know the sequences of these two 
rnRNAs. We now report the cloning of a human kidney 
MAT (kidney-type isozyme) cDNA, the determination 
of the nucleotide sequence and derived amino acid se- 
quence, and the sequence comparison of human kidney 
MAT with previously described human liver (liver-type) 
MAT. We have also investigated the developmental ex- 
pression of the mRNAs for human isozymes. 
2. MATERIALS AND METHODS 
[a-‘?P]dCTP, [z-“sS]dATP and Hybond-N nylon membranes were 
obtained from Amersham Corp. Restriction enzymes, DNA-modify- 
ing enzymes. a random-primed DNA labeling kit, and random hcx- 
amers ((dN)J were from Takara Shuzo Co. (Kyoto. Japan). Avian 
mycloblastosis virus reverse transcriptax XL was from Life Scicnccs. 
The scquenase DNA sequencing kit was from United States Biochcm- 
ical Corp. A human kidney ilgtl I cDNA library and fetal (?I-wcck- 
old) human liver poly(A)’ RNA were from Clontech Laboratories Inc. 
GcneAmp DNA amplificalion reagent kit was from Perkin Elmer 
C&us. All other chemicals and reagents were of analytical grade and 
obtained from commercial suppliers. 
2. I, Clorling and scrjlrenciflg oJr/~e cDNA sxoding hrrnmn kidney MAT 
A human kidney cDNA library in &tl I plated on Exher\chiu coli 
LE392 was screened by standard plaque hybridhtion techniques [IO] 
using the EcoKl insert of rat kidney MAT cDNA [4]. The probe was 
labclled using the random primer method [I I]. Phagc and plasmid 
DNA isolations, restriction analysis, subcloning, and subsequent re- 
combinations were performed using standard procedures [IO]. 
2.2. Nuclroride seqtmcc arlalysls 
DNA sequencing was carried out on both strands of isolated clones 
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by the dideoxy chain-~erminntion method [IZ]. using [“)S]dATP and 
sequenasc. 
Total RNA was prepared from human kidney and liver by the 
method of Chirgwin ct al. [13]. Poly(A)’ RNA was isolated by 
oligo(dT)-cellulose chromatography [14]. 
Poly(A)’ RNA (1 pg) was incubated for 60 min at 42°C in a reaction 
mixture (50~1) containing 50 mM Tris-HCI (pH S.3), 75 mM KCI, 3 
mM MgQ, 10 mM dithiothreitol, 5 nmol of each dcoxynucleotidc 
triphospha~e (dNTP). 5 U ofribonucleasc inhibitor from human pla- 
centa, 100 pmol of random hcxilmer primers, and 20 U of Avian 
myeloblaslosis virus reverse lranscriptasc. I ~1 of the product was 
subsequcnlly subjected to the PCR using n GeneAmp DNA Amplifi- 
cation kit in a total volume of 50/k Tlx mixture was incubated for 
25 cycles: denaturation, I min 8194OC; annealing, I min at 54OC; and 
polymerization. 2 min at 72°C. The last cycle ended with 7 min at 72°C 
and gradually cooled to ambienl temperalure. The sizes of the resuh- 
ing PCR products were analyzed by clbxtrophoresis in a 2% agarosc 
gel. The PCR product was purified on agarose &cl. phosphoryluwd 
with ATP and T4 polynucleoiidc kinasc. and cloned into pUCl I9 
plasmid al the S~rrl site. The nucleotide sequences wcrc dctcrmined 
as described. 
I & ol’ poly(A)+ RNA from human kidney was denatured and 
-65 TTTCGCAGCCGCTGCCCCCTCGCCGCTGCTCCTTCGTAAGGCCACTTCCGCACACCGACACCAAC 
1 ATGAACGOACAO~TCAA~OGCTTCCACGAGGCGTTCA'I'CGAGGAGGGCACATTCCTT'~TCACCTCAGAGTCGG'~CGGGGAAGGCCAC 
1 MetAsnClyGlnLeuAsnOlyPheHisGluAlnPl~eSleGluGluGlyThrPheLeuPheThrSerGluSerValGlyGluGlyl-lis 
85 CCAGATAAGATTTOTGACCAAA'~CAGTGATGCTGTCCTTGATGCCCACCTTCAGCAGCA'rCCTCATGCCAAAOTAGCTTGTGAAACT 
30 ProAspLysIleCysAspGlnIleSerAspAlaValLeuAspAlallisLouGlnGlnAspProAspAlaLysValAlaCYSOlUT~~r 
175 G1'TGCTAAAACTGGAATGATCC'QTCTTGCTGGGGAAATTACATCCAGAGCTGC'~GTTGACTACCAGAAAGTGGTTCGTGAAGCTGTT 
59 ValAlaLys'~hrGlyMetIleLcuLcuAlaGlyGluIleThrSe~~ArgAlaAlaVnlAspTyrGlnLysValValA~~gGluAlaVal 
262 AAACACATTGGATATGA'FGATTCTTCCAAAGGT'~TTGACTACAAGAC'~TGTAACGTGCTGGTAGCCTTGGAGCAACAGTCACCAGAT 
A8 Lysl~isIleGlyTyrAspAspSe~SerLysGlyPheAsp'~yrLys'~hrCysAs~~ValLeuValAlaLeuCluGl~~GlnSerPr~AsP 
349 ATTGCTCAAGUTGTTCATCTTGACAGAAATGAAGAAGACATTGGTGCTGGAGACCAGGGCTTAATQTTTGGCTATOCCACTGATGAA 
117 IleAluGlnGlyVnltlisLeuAspArp,AsnGluGluAspIlcGlyhlaG1yAspGlnGlyLcu#etPheGly'l'yrAlaT~~rA~pGlu 
$36 ACTGAGGAGTGTh'rGCCTTTAACCAT1'GTCTTGGCACACAAGCTAAATGCCAAACfrGUCAGAACTACGCCGTAA'rGGCACTTTGCCT 
146 ThrGluGluCysMetProLouThr1leVolL~uAlallisLysLeuAsnAlaLysLeuAlaGluLeuArgAr6AsnGlyTl~rLeuPro 
523 'I'GG'r'l'ACGCCCTGA'~'rC'~AAAACTCAAGT'rACTGTGCAGTATATGCAGGATCGAGGTGCTGTGCTTCCCATCAGAGTCCACACAATT 
175 Trpl,euArgPraAspSe~LysTh~Glr~Vnl'~hrValGln'~yrMetGl~~AspArgGlyAlnValLeuProIleArgVul~lis'~hrIle 
610 GTTATATCTGTTCAGCA'rGATGAAGAGGTTTGTCTTGATGAAATGAG~~ ~ ATGCCCTAAAGC:AOAAAGTCATCAAAGCAGTTGTGCCT 
204 ValIleSerVulGlr~llisAsPGluUluVnlCysLeuAspOluMetArgAspAlaLeuLYsGluLYsValIleL~~sAIaValValPro 
697 GCGAAATACCTTGATCAGGATACAATCTACCACCTACAGCCAAGTGGCAOATTTG'~TATTGGTGGGCCTCAGGGTGATGC'~GGTTTG 
233 AlaLysTyrLcuAspGluAsp'rhrIleTy~HisLeuGlnP~~oSerGlyArgPheValIleGlyGlyProGlnOlyAspAlnOlyLeu 
784 ACTGGACGGAAAATCATTGTGGACACTTATGGCGGTTGGGGTGC~CATGGAGGAGGTOCCTTTTCAGGAAAOOATTATACCAAGG'~C 
262 ThrGlyA~~gLysIlclleValAsp'~hr'ryrGlyGlyTrpGlyAla~li~GlyOlyGlYAlaPheSeralyLysAsp'~yr'~hrLysVal 
l3'71 GACCGTTCAGC1'GCTTATGCTGCTCGTTGGGTGGCAAAATCCCTTGTTAAAGGAGGTCTGTGCCGGAOGO'~TCTTGTTCAGGTCTCT 
291 AapArgSerAlaAla'~yrAlaAlaArg'~rpValAlaLysSerLeuValLysGlyOlyLeuCysArgArgVa~LeuValGl~Val~e~ 
058 TA'I'GCTA'r'~GGAGT'I"~CTCATCCATTATCTATCTCCAT'~Tr~CCATTATGGTACCTCTCAGAAGAOTG~~GAGAGAGCTATTAGAGATT 
320 ‘~yrAlnfl~GlyVnlScrllisProLeuScrlleS~rIlePheliis’~yrGly’~hrSe~GlnLysSerGluAr~GlULeuLeuGluIl~ 
1132 GGCCACTT'rGCTI\GGGACAGCTTCCCATGGGAAG'I'TCCCCAGACTTGT~ 
378 GlyllisI'l~eGly~~rgAspSerPhcProT~pGiuValP~oi,ysLy~LeuLy~Tyt * 
Fig. I. Nuclcotide scqucnce and deduced amino acid scquencc of the human kidney S-adcnosylmethioninc synthetase. Nuclcotides are numbcrcd 
beginning with the prediclcd N-lcrminal rcsiduc. The asterisk indicates a translation termination codon. 
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separated on a 1.0% agarose gel as described by Thomas [IS], then 
transferred to Hybond-N nylon membranes. Prchybridizition and 
hybridization of the membranes were performed as described [4], 
HKSAMI cDNA probe was labelled by the random primer DNA 
labeling kit. 
A sample of the PCR mixture (5 ~1) was added to 5 ~1 of loading 
buffer (50% glycerol, 0.23% Bromophcnol blue, xylcnecyanol FF) and 
size-fractionated by elL%trophoresis in a I-mm thick non-denaturing 
B% polyacrylamide gel. Gels wcrc stained in ethidium bromide (0.5 
ydml), de-stained in water, and examined on a ultraviolet r;ins- 
illuminator. Gels were photographed using an orange filter and Polar- 
oid 665 positive/negative film. 
3. RESULTS AND DISCUSSION 
3.1. Isolatiort attd seqrrerice anulpis of cL?NA clones 
Using a rat kidney MAT cDNA as a probe, we 
screened about 200,000 clones from a human kidney 
cDNA library and obtained several clones. The purified 
clones contained cDNA inserts of sizes ranging over 
1 .O-1.8 kbp. The largest cDNA clone, HKSAMI, was 
subjected to further analysis. The cDNA was 1,840 bp 
in length and, when compared with the cDNA encoding 
II. I ,I * **,.*********.**.. ****.*** a*. .*.*a*** 
IIK MNt9LNUPll~AFIE-KO’PBLWSEYYOEOIII’DKlCU~lSDAVLDAllLQQDl’DAKVAC~~V 
HK MNGQl.~OFIIEAPIK-EO1’FLFTSESVOK~IIPDKlCD~lNDAVLUAIII.PQDI’DAKVAC~TV 
I,,. MNOPVDPLCDIISI.6-EOVFMF’~SKSV~EGllPDKlCDQlSDAVI.DAIiI.KPDFNAKVACKTV 
RL MNOI’VL)OtCUIISLSEEOAPMFl~SESVOeOllPDKICD~lSDAVLDAIILKPDPIIAKVhCETY 
t.1. 11 *n*** * .I. *** **I***** lllf ‘C****~*,****..*L* 
AKTOMtLLAOBA~I’SRAAVDY~KVVR~AVKlltOYl~DSSKGl~DYKTCNVLVALkQ~S~~IA~ 
AKTGMILLAOEITSRAAtDYPKVVR~AlKIIIOYDDSSKOPDYKTCNVLVALEPSYI’DIAP 
CKTOMVLLCGEl’~YMhMVDYSRYYRDTlKllI~YD~SAK~FDFKTCNV~VALK~QSPDlAQ 
CKTOMVLLCOElTSMAMtDYQRVVRDTlKlllGYDDSAK~FDF~~CNV~VALSQQSi~DlA~ 
l ******** l *******ll*llll~l~L*~*~. 1111.1 . LLI l .*I*.** 
OVHI.OkNEEDIOAODQ0LMP~YATDETEECMPI.1’1~~Rl~D 
OVIILDRllEEDIOAOU~OLMFO~A’~D~TKRCRPl,Tt’JLAllK~NAKl.AELRRf~~’~L~WI,RPD 
CVIILDRNEEDVGAODQOU,FEYATDETEECMPLTt ILAIIKLHAkMADI.RRSOl~LPWLRl~~ 
CVIILDRNEBDVGAODQOLHFG~ATDETEBCRPLTIVI.AlIKLN’PRRADLRRSOVLPWLIll’D 
****1**** I. a*. * L l ll**ll** I I II 111, I l .ILI****** 
SKT4V’~V4YRQDH~AVLl~IRVllTlVISVQIIDEEYCD 
SKT~V‘PVQYMFIDROAVtPIRVIITIVISVQIIDEKVCI.DEMHDALKEKL1KAVVPAKYi.DtiD 
YKTPVTVYY~PDNOAVtI’VRIllTIVlSV~llNEDITl.KRMRl~ALKK~VlRAVV~AKYLDKU 
5KT~VTVQYVQDNGAVIPVRVl~TtVISV~llN~DlTLEA~RRA~KK~VtKAVVPAKYLD~D 
* .*,,*,4*****,****** I******..* ICI*,.*II*I~**AIII..*~~..* 
‘~IYllL~~SGRFV100PQ0UAflLT~HKlIVDTYO(lW~AllOGOAFSGKD7TKVDRSAAYAAl~ 
TIYIIL~PS(IRPVlOOP~~DAOLT~l~Kl tVDTYGPWtlAllCl00Al’SOKDYTKVDRYAAYAAR 
TVYIIL~FSORFVI[IOP40DAGVTORKlIVDTYAAWOAllOG0Al’50KDYTKVDRSAAYAAR 
TlYllL9PSr*HPVIOOP4ODA~V~kKllVDTYOOWOhllDGGAFSGKDYTKVDRSAAYAAR 
****L***.****s *I: a***** *.***a II 
VtVkDl.DLKKPlYQRTAAYClllFORDSFPWEVPKKLKT 
YIVRDLDLKKPIYPRTAAYOllFORDSFI’HEVPKKLKY 
VIVRDLDLKKPIYEjKTACYOllFCRSKFPWEVPRKLVr 
VIVRDLDtKKPlYqKTACYGllFURSEFPWEVPKKU’F 
Fig. 2. Comparison of the deduced amino acid sequence of human 
kidney S-adcnosylmcthionine synthetasc (HK) with those of humaa 
liver (WL), rat kidney (RK), and rat liver (RL) S-adenosylmcthioninc 
synthetascs. Amino acids are represented bythe sir&-letter code. The 
sequences arc aligned for maximum similarity and gaps arc indicated 
by &&AU. Asterisks danoic amino acids cozscrved in 91 four S- 
adenosylmethioninc synthelases. The sequence data have been taken 
from the following references: human liver [9]; rat kidney 141; rat liver 
171. 
the rat kidney counterpart, itseemed to be derived from 
an incompletely processed mRNA, containing a short 
unexcised intron of 635 bp in length (between ucleotide 
residues 1,085 and 1,086 in Fig. 1). To ensure that the 
intron-like sequence of 635 bp was absent in the mature 
mRNA, PCR was performed with primers that allowed 
amplification of the sequence across the intron-like seg- 
ment. Poly(A)+ RNA from human kidney was isolated 
and first strand cDNA was synthesized by random hex- 
amer-primer reverse transcription. Such single-stranded 
cDNA was used as a template for DNA amplification 
by PCR using two primers (nucleotide residues 879-898 
and 1,210-1,229) synthesized according to the nucleo- 
tide sequence of human kidney MAT. An amplified 
product of 351 bp in length was only detected by aga- 
rose gel electrophoresis. This result showed that the 
intron-like segment observed in HKSAMl was com- 
pletely excluded from the human kidney MAT mRNA 
sequence. This PCR product was subcloned into the 
pUC 119 vector and the DNA sequence of the insert was 
determined from a purilied clone. The nucleotide se- 
quence of the insert cDNA was found to be 100% identi- 
cal to the corresponding region of the MKSAMl cDNA 
except for the intron-like sequence. 
The nucleotide sequence of the coding region and 
deduced amino acid sequence is shown in Fig. 1. The 
open reading frame, starting with the S-most ATG 
codon at position ! through 3, and terminating with a 
TGA codon at 1,186 through 1,189, encoded a 395 
amino acid polypeptide, giving a calculated molecular 
mass of 43,660 Da. The codon specifying the N-termi- 
nus of the protein was inferred by aligning the deduced 
amino acid sequence of human MAT with the published 
sequence of rat kidney counterpart [4], The initiator 
methionine is localized at the same position as the rat 
sequence. The ACCAACATG sequence around this pu- 
tative initiation site is in reasonable agreement with the 
consensus equence for translation [l6]. Thus, it seems 
likely that this ATG is the translational initiation 
codon. 
A comparison of the predicted amino acid sequence 
of human kidney MAT with those of human liver [9], 
rat liver [7], and rat kidney [4] isozymes is presented in 
Fig. 2. The human kidney enzyme showed 84,84, and 
99% similarity with human liver, rat liver, and rat kid- 
ney isozymes, respectively. The amino acid sequences of
human kidney and liver MAT proteins are 84% identi- 
cal throughout heir length. This level of sequence sim- 
ilarity suggests that our cloned human kidney MAT 
protein seems to be a catalytic subunit. 
3.3. Norrltetw hlorrirtg 
Northern blot analysis was performed using the en- 
tire insert of HKSAMl cDNA as a probe. Probing of 
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Origin - 
.i 
2 8 s - :_ ?/3.8 kb 
I8s- ,-\3.4 kb 
Fig. 3. RNA blot analysis. Poly(A)’ RNA extracted from adult human 
kidney was hybridized to the HKSAMI probe. 28 S (4.8 kb) and IS 
S (1.9 kb) human kidney rRNA were used as size markers. RNA sizes 
in kb arc indicated on the right. 
poly(A)’ RNA derived from human kidney revea!ed 
two mRNA species of 3.4 and 3.8 kb in length (Pig. 3). 
The 3.4 kb band was the most abundant. 
3.4 Developmental expression of MAT isozymr mRNAs 
We have previously shown, by determining the en- 
zyme activities, that the kidney-type MAT predomi- 
nantly existed in fetal rat liver and was progressively 
replaced by the liver-type isozyme during development 
[17]. However, the availability of these two human 
MAT isozyme cDNA sequences allowed us to examine 
the expression of both isozyme mRNAs in the fetal and 
adult human livers using the more sensitive RT-PCR 
method. Poly(A)’ RNAs extracted from human kidney, 
fetal (21-week-old) human liver, and adult (78-year-old) 
human liver were reverse transcribed to obtain comple- 
mentary DNAs for PCR amplification. Primers used in 
the PCR amplification were designed to amplify the 
human kidney-type (primer pair K: nucleotide residues 
24-43 and 210-229 in Fig. 1) and liver-type (primer pair 
L: nucleotide residues 24-43 and 171-190 in [9]) MAT 
sequences of 206 bp and 167 bp, respectively. When 
cDNA derived from adult human kidney RNA was 
amplified, a single band was only detected at the size 
(206 bp) of the product expected from the kidney-type 
MAT using primer pair K (Fig. 4, lane 1). However, no 
PCR product was observed using primer pair L (lane 2). 
In contrast, the PCR products derived from adu!t 
human liver contained a major band (167 bp) of the 
liver-type MAT (lane 4), whereas the kidney-type MAT 
was faintly detected (lane 3). This experiment clearly 
Origin 
I330 
536/517 
396 
221 
123456 
206 
167 
Fig. 4. Ethidium bromide-stained polyacrylamide gel of RT-PCR 
products. cDNAs from adult human kidney (lanes I and 2), adul: 
human liver (lanes 3 and 4), and fetal human liver (lanes 5 and 6) were 
amplified using primer pair K (lanes I, 3 and 5) or primer pair L (lanes 
2,4 and 6). Size markers (pUCI 18IHinfl fragments) inbp are indicated 
on the left. PCR products in bp arc indicated on the right. 
showed that the kidney-type MAT mRNA was cx- 
pressed at very low levels in the adult liver. These results 
indicated that the RT-PCR analysis accurately ampli- 
fed the target regions, and the products were not the 
results of amplification of genomic DNAs. Furiher- 
more, we have examined the expression of MAT 
isozyme mRNAs in the fetal human liver. The results 
showed that both kidney- and liver-type MAT mRNAs 
were expressed in fetal human liver and the kidney-type 
MAT mRNA was relatively abundant (lanes 5 and 6). 
It is considered to be somewhat difficult to derive abso- 
lute quantitative conclusions from PCR. However, we 
suggest that the differences in kidney-type MAT prod- 
uct levels within each sample reported here are likely to 
accurately reflect relative differences in mRNA levels. 
Our results are generally consistent with previous stud- 
ies on the developmental expression of MAT isozymes 
in the rat liver [9]. These findings uggest that, from fetal 
to adult, the expression of these two MAT isozymes is 
developmentally regulated. 
This cDNA will be a useful tool for future studies to 
understand the mechanisms of the tissue- and stage- 
specific gene regulation. 
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